13 – Opioids II Flashcards
1
Q
Opioids clinical use
A
- Premedication
- Bolus or infusion intra- and peri-operatively
o Dose-dependent analgesia
o Great anesthetic sparing effect - Analgesia for medical and critically ill patients
- Procedural sedation
o Combination with sedatives
o Sedation
2
Q
Adverse effects of opioids
A
- Behavioural changes
- Vomiting and nausea
- Increased risk of gastroesophageal reflux (GER)
- Bradycardia
- Respiratory depression
3
Q
CNS
A
- Sedation
- Euphoria (more common in cats)
- Dysphoria (more common in dogs)
4
Q
Euphoria dogs + cats
A
- Dogs: extreme wakefulness, vocalization
- *Cats: extreme friendliness, kneading, rolling
- May OUTLAST analgesic effects
5
Q
Dysphoria dogs + cats
A
- *Dogs: agitation, excitement, excessive vocalization
- Cats: fearful, apparent hallucinatory behaviour, circling, pacing
- More likely in NON-painful in animals
- *reaction to ‘overdose’ of opioids
6
Q
Dysphoria treatment
A
- Partial opioid reversal (careful titration)
- Sedation (low dose acepromazine, dexmedetomidine)
o Maybe do not for older animals
7
Q
Partial opioid reversal to ‘treat’ dysphoria
A
- Butorphanol
- Naloxone
8
Q
Dose-dependent respiratory depression (mu-opioid agonists)
A
- Hypoventilation and hypercapnia
- Mu-opioid receptor decreases responsiveness of regulatory cells to pCO2 and pH
- Humans are more susceptible than animals
- Panting in dogs (to decrease body T: hypothermia)
9
Q
Antitussive actions
A
- Depression of cough reflex
- Independent of respiratory depressant effects
- Butorphanol 100x/4x more effective than codeine/morphine
10
Q
CV effects
A
- Minimal effects on CO, cardiac rhythm, arterial BP
- Vagally mediated bradycardia
- Reversible with anticholinergic drugs
- Histamine release: vasodilation and hypotension (morphine, meperidine)
11
Q
Mu agonist opioids nausea and emesis effects
A
- Emetic effect: stimulation of dopamine receptors in CTZ (apomorphine)
- Antiemetic effect: inhibition of emetic center inside the BBB
o Use of antidopaminergic drugs may decrease incidence of vomiting
12
Q
Kappa agonist opioids nausea and emesis effects
A
- Butorphanol: antiemetic for chemotherapy
13
Q
GI tract effects
A
- Decreased motility
- Gastro-esophageal reflux (GER)
14
Q
Decreased motility (GI)
A
- Inhibit release of NT=impair coordination of motility and inhibition of GIT
- Initial effect=defecation
- Followed by ileus and constipation
15
Q
Gastro-esophageal reflux (GER)
A
- Gastro-esophageal sphincter relaxation
- Hydromorphone, methadone